All these new studies indicate that there is a significant relationship between IL-40 in serum and the occurrence of RA, SLE, pSS, lymphoma, and other possible diseases, which may not have been discovered yet, and they support the use of IL-40 as a potential biomarker for diagnosis. This evidence concerns the gene C17orf99 and lymphoma.